IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel ...
"These guys have come up with a really elegant way in which to recharge devices that are implanted in the body," Cohen said ...
A 41-year-old nurse from Severance shopping for a solution to her overactive bladder symptoms found a way to regain full control thanks to an innovative procedure. Sarah Avrech said goodbye to a life ...
As of October 5, 2023, the average one-year price target for Axonics is 77.91. The forecasts range from a low of 60.60 to a high of $99.75. The average price target represents an increase of 43.14% ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback